Skip to main content
GRDN
NYSE Trade & Services

CEO Sells $19.9M in Shares as Part of Secondary Offering

Analysis by Wiseek.ai
Sentiment info
Negative
Importance info
9
Price
$37.57
Mkt Cap
$2.379B
52W Low
$19.17
52W High
$38.12
Market data snapshot near publication time

summarizeSummary

Fred Burke, President and CEO of Guardian Pharmacy Services, sold 671,432 shares for nearly $20 million as part of a previously announced secondary offering.


check_boxKey Events

  • CEO Sells Significant Stake

    Fred Burke, President and Chief Executive Officer, sold 671,432 shares of Class A Common Stock.

  • Substantial Proceeds

    The sale generated approximately $19.9 million in proceeds for the CEO.

  • Part of Secondary Offering

    The transaction was executed on March 20, 2026, as part of a secondary offering finalized on March 23, 2026, where selling stockholders disposed of 5.88 million shares.

  • Sale at Discounted Offering Price

    The shares were sold at $29.68 per share as part of the secondary offering, which was priced at a discount to the market. The current stock price is $37.57.


auto_awesomeAnalysis

This Form 4 filing details a significant sale by Fred Burke, the President and CEO, disposing of 671,432 shares for approximately $19.9 million. This transaction, executed at $29.68 per share, was part of a secondary offering finalized on March 23, 2026, which was priced at a discount to the market. The sale by a top executive, especially when the stock is trading near its 52-week high and significantly above the offering price, could be interpreted negatively by investors, signaling a decision to realize gains or a lack of conviction in further near-term appreciation, despite being part of a broader capital event. This follows other insider sales related to the same offering.

At the time of this filing, GRDN was trading at $37.57 on NYSE in the Trade & Services sector, with a market capitalization of approximately $2.4B. The 52-week trading range was $19.17 to $38.12. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed GRDN - Latest Insights

GRDN
Mar 26, 2026, 7:18 AM EDT
Filing Type: DEF 14A
Importance Score:
8
GRDN
Mar 24, 2026, 6:17 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
GRDN
Mar 24, 2026, 4:15 PM EDT
Filing Type: 4
Importance Score:
7
GRDN
Mar 24, 2026, 4:15 PM EDT
Filing Type: 4
Importance Score:
8
GRDN
Mar 24, 2026, 4:15 PM EDT
Filing Type: 4
Importance Score:
9
GRDN
Mar 24, 2026, 4:15 PM EDT
Filing Type: 4
Importance Score:
7
GRDN
Mar 24, 2026, 4:15 PM EDT
Filing Type: 4
Importance Score:
7
GRDN
Mar 24, 2026, 4:15 PM EDT
Filing Type: 4
Importance Score:
8
GRDN
Mar 24, 2026, 4:15 PM EDT
Filing Type: 4
Importance Score:
7
GRDN
Mar 24, 2026, 4:15 PM EDT
Filing Type: 4
Importance Score:
8